ReNeuron Group plc (LON:RENE – Get Free Report)’s share price crossed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of GBX 3.38 ($0.04) and traded as high as GBX 3.50 ($0.04). ReNeuron Group shares last traded at GBX 3.38 ($0.04), with a volume of 177,373 shares traded.
ReNeuron Group Trading Down 2.2 %
The company has a debt-to-equity ratio of 14.25, a quick ratio of 2.02 and a current ratio of 1.51. The stock has a market cap of £1.93 million, a PE ratio of -37.50 and a beta of 0.69. The business has a 50-day moving average of GBX 3.38 and a 200 day moving average of GBX 4.21.
ReNeuron Group Company Profile
ReNeuron Group plc researches, develops, and commercializes cell-based therapies in the United Kingdom. The company engages in the development of CTX stem cell therapy candidate for treating stroke disability; and human retinal progenitor cell therapy that is in Phase 2 clinical trial for treating retinitis pigmentosa, a blindness-causing disease.
See Also
- Five stocks we like better than ReNeuron Group
- Using the MarketBeat Stock Split Calculator
- Comprehensive PepsiCo Stock Analysis
- What is a Secondary Public Offering? What Investors Need to Know
- CSX Co.: The Railroad Powering Ahead with an Earnings Beat
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Bear Market Funds to Watch This Year
Receive News & Ratings for ReNeuron Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ReNeuron Group and related companies with MarketBeat.com's FREE daily email newsletter.
